Globus Medical Inc (GMED)
51.95
+1.47
(+2.91%)
USD |
NYSE |
May 03, 16:00
51.94
0.00 (0.00%)
After-Hours: 20:00
Globus Medical SG&A Expense (Quarterly): 244.72M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 244.72M |
September 30, 2023 | 156.21M |
June 30, 2023 | 120.07M |
March 31, 2023 | 122.42M |
December 31, 2022 | 118.08M |
September 30, 2022 | 106.58M |
June 30, 2022 | 106.72M |
March 31, 2022 | 100.75M |
December 31, 2021 | 106.56M |
September 30, 2021 | 96.44M |
June 30, 2021 | 107.25M |
March 31, 2021 | 97.89M |
December 31, 2020 | 92.05M |
September 30, 2020 | 89.15M |
June 30, 2020 | 80.02M |
March 31, 2020 | 93.54M |
December 31, 2019 | 92.14M |
September 30, 2019 | 88.46M |
June 30, 2019 | 88.38M |
March 31, 2019 | 85.78M |
December 31, 2018 | 83.64M |
September 30, 2018 | 75.13M |
June 30, 2018 | 77.12M |
March 31, 2018 | 75.69M |
December 31, 2017 | 72.96M |
Date | Value |
---|---|
September 30, 2017 | 63.36M |
June 30, 2017 | 64.44M |
March 31, 2017 | 67.06M |
December 31, 2016 | 60.84M |
September 30, 2016 | 54.21M |
June 30, 2016 | 53.31M |
March 31, 2016 | 53.80M |
December 31, 2015 | 52.80M |
September 30, 2015 | 52.17M |
June 30, 2015 | 54.51M |
March 31, 2015 | 52.29M |
December 31, 2014 | 48.54M |
September 30, 2014 | 46.99M |
June 30, 2014 | 46.42M |
March 31, 2014 | 46.68M |
December 31, 2013 | 45.67M |
September 30, 2013 | 45.70M |
June 30, 2013 | 45.75M |
March 31, 2013 | 45.40M |
December 31, 2012 | 44.63M |
September 30, 2012 | 41.78M |
June 30, 2012 | 41.23M |
March 31, 2012 | 41.22M |
December 31, 2011 | 37.86M |
September 30, 2011 | 34.76M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
80.02M
Minimum
Jun 2020
244.72M
Maximum
Dec 2023
110.92M
Average
100.75M
Median
Mar 2022
SG&A Expense (Quarterly) Benchmarks
Stryker Corp | 1.84B |
Glaukos Corp | 61.98M |
PROCEPT BioRobotics Corp | 39.60M |
Paragon 28 Inc | 48.25M |
Alphatec Holdings Inc | 104.12M |